Leo Pharm Company Profile

✉ Email this page to a colleague

LEO PHARM has thirteen approved drugs.

There are thirteen US patents protecting LEO PHARM drugs.

There are two hundred and thirteen patent family members on LEO PHARM drugs in thirty-eight countries and twenty-two supplementary protection certificates in fourteen countries.

International Patents:	213
US Patents:	13
Tradenames:	9
Ingredients:	8
NDAs:	13
Drug Master File Entries:	2
Patent Litigation for Leo Pharm:	See patent lawsuits for Leo Pharm

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Leo Pharma As	FINACEA	azelaic acid	AEROSOL, FOAM;TOPICAL	207071-001	Jul 29, 2015		RX	Yes	Yes	10,117,812	⤷ Start Trial	Y			⤷ Start Trial
Leo Pharma As	FINACEA	azelaic acid	AEROSOL, FOAM;TOPICAL	207071-001	Jul 29, 2015		RX	Yes	Yes	7,700,076	⤷ Start Trial	Y			⤷ Start Trial
Leo Pharma As	ENSTILAR	betamethasone dipropionate; calcipotriene	AEROSOL, FOAM;TOPICAL	207589-001	Oct 16, 2015		RX	Yes	Yes	9,119,781*PED	⤷ Start Trial			Y	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Leo Pharma As	FINACEA	azelaic acid	AEROSOL, FOAM;TOPICAL	207071-001	Jul 29, 2015	8,435,498	⤷ Start Trial
Leo Pharma As	FINACEA	azelaic acid	AEROSOL, FOAM;TOPICAL	207071-001	Jul 29, 2015	10,322,085	⤷ Start Trial
Leo Pharma As	DOVONEX	calcipotriene	CREAM;TOPICAL	020554-001	Jul 22, 1996	RE39706	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Solution	0.01%	➤ Subscribe	2006-05-19
➤ Subscribe	Topical Foam	15%	➤ Subscribe	2017-09-14
➤ Subscribe	Ointment	0.1%	➤ Subscribe	2010-09-09
➤ Subscribe	Ointment	0.005%/0.064%	➤ Subscribe	2010-03-31
➤ Subscribe	Gel	15%	➤ Subscribe	2012-07-27
➤ Subscribe	Gel	0.05%	➤ Subscribe	2010-12-01
➤ Subscribe	Ointment	0.03%	➤ Subscribe	2010-11-22

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Portugal	2579852	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2008152444	⤷ Start Trial
Australia	2006273697	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2460806	PA2025511	Lithuania	⤷ Start Trial	PRODUCT NAME: DELGOCITINIBAS VISOMIS FORMOMIS SAUGOMOMIS PAGRINDINIO PATENTO; REGISTRATION NO/DATE: EU/1/24/1851 20240919
2460806	122025000013	Germany	⤷ Start Trial	PRODUCT NAME: DELGOCITINIB IN ALLEN DURCH DAS GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/24/1851 20240919
2460806	CA 2025 00010	Denmark	⤷ Start Trial	PRODUCT NAME: DELGOCITINIB I ALLE FORMER BESKYTTET AF BASISPATENTET; REG. NO/DATE: EU/1/24/1851 20240923
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.